ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Skin Diseases
Immune System Diseases
Eczematous Skin Diseases
Food Hypersensitivity
Genetic Skin Diseases

Eczema trials near Phoenix, AZ, USA:

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have ...

Enrolling
Eczema, Atopic
Atopic Dermatitis
Drug: PF-08049820
Drug: Placebo

Phase 2

Pfizer
Pfizer

Phoenix, Arizona, United States and 41 other locations

in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema (also called atopic dermatitis) is a common sk...

Enrolling
Atopic Dermatitis
Drug: Placebo
Drug: Tilrekimig

Phase 3

Pfizer
Pfizer

Scottsdale, Arizona, United States of America and 20 other locations

in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema is a condition which can cause dryness, itchin...

Enrolling
Atopic Dermatitis
Drug: Tilrekimig
Drug: Dupilumab

Phase 3

Pfizer
Pfizer

Phoenix, Arizona, United States and 31 other locations

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Enrolling
Eczema Atopic Dermatitis
Eczema, Atopic
Drug: Camoteskimab
Drug: Placebo

Phase 2

Apollo Therapeutics

Phoenix, Arizona, United States of America and 84 other locations

The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...

Active, not recruiting
Eczema
Atopic Dermatitis
Drug: Placebo
Drug: Lebrikizumab

Phase 3

Lilly
Lilly

Phoenix, Arizona, United States and 88 other locations

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Active, not recruiting
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo

Phase 2

Bluefin Biomedicine, Inc.

Phoenix, Arizona, United States and 88 other locations

The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to \<18 years of age with mode...

Invitation-only
Eczema
Atopic Dermatitis
Drug: Placebo
Drug: Lebrikizumab

Phase 3

Lilly
Lilly

Phoenix, Arizona, United States and 95 other locations

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.

Active, not recruiting
Eczema
Atopic Dermatitis
Drug: ATI-045
Drug: Placebo

Phase 2

Aclaris Therapeutics
Aclaris Therapeutics

Phoenix, Arizona, United States and 60 other locations

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Active, not recruiting
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo

Phase 2

Pfizer
Pfizer

Phoenix, Arizona, United States and 100 other locations

The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of ado...

Active, not recruiting
Atopic Dermatitis
Drug: Placebo
Drug: Upadacitinib

Phase 3

AbbVie
AbbVie

Scottsdale, Arizona, United States and 193 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems